Clinical Trial Update: Tolerance of Extensive Hydrolyzed Whey Protein Milk Among Infant With Mild to Moderate CMPA [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tolerance of an extensively hydrolyzed whey protein formula in infants with cow's milk protein allergy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Protein Allergy

Drugs mentioned

• Extensively hydrolyzed whey protein formula

Snippet

Sponsor: Danone Specialized Nutrition Indonesia | Conditions: Mild to Moderate Cows' Milk Protein Allergy | Phase 4 | Status: TERMINATED